Cover Image
市場調查報告書

體外診斷(IVD)市場預測

Global In-Vitro Diagnostics Market Forecast to 2018

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 299703
出版日期 內容資訊 英文 145 Pages
訂單完成後即時交付
價格
Back to Top
體外診斷(IVD)市場預測 Global In-Vitro Diagnostics Market Forecast to 2018
出版日期: 2014年04月01日 內容資訊: 英文 145 Pages
簡介

全球體外診斷(IVD)市場,2013年達到554億美元規模,預計2013年∼2018年以CAGR約7%成長。

本報告提供全球IVD市場相關調查分析、市場趨勢與實際成果、市場預測、各地區分析、各市場區隔分析、主要企業簡介,為您概述為以下內容。

第1章 分析師的見解

第2章 調查手法

第3章 IVD市場概要

  • 簡介
  • 所謂IVD
  • 市場規模與成長率

第4章 各臨床預測

  • 重點照護(POC)診斷
  • 免疫化學
  • 臨床化學
  • 分子診斷
  • 血液學
  • 微生物學
  • 止血
  • 免疫血液學

第5章 各地區的預測(現在/未來方案)

  • 南北美洲
  • 歐洲
  • 亞太地區

第6章 產業趨勢

  • 循環腫瘤細胞(CTC)用設備
  • 癌症的非侵入性遺傳基因檢驗
  • 非侵入性產前診斷市場
  • 搭配診斷藥
  • 癌症的預測診斷檢驗市場
  • POCT

第7章 競爭情形

  • 主要企業的市場佔有率
  • 主要企業
    • Abbott Laboratories
    • Alere, Inc.
    • Becton Dickinson
    • Bayer HealthCare
    • Beckman Coulter
    • Biomerieux
    • Johnson and Johnson
    • Life Technologies Corporation
    • Medtronic, Inc.
    • Qiagen NV
    • Roche Holding Ltd
    • Sysmex Corporation
    • Siemens HealthCare
    • Thermo Fisher Scientific

圖表

目錄

Driven by factors, such as increasing prevalence of chronic diseases, rising demand for POCT and technological advancements in the global market, the IVD market is going through a very exciting phase. Presently, the market is dominated by developed countries; however, rising economies such as India, Brazil and China are likely to witness strong growth in the coming years.

In the latest research study, “Global In-Vitro Diagnostics Market Forecast to 2018”, RNCOS analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 55.4 Billion in 2013, is expected to grow at a CAGR of around 7% during 2013-2018.

The market has been segmented keeping in mind three factors: Clinical use, Geographical scenario and Player specializations, and for every segment a current and future outlook to 2018 has been provided. For regional analysis, key IVD markets that together constitute around 95% of the global market, have been profiled. Through this research, opportunity assessment in various segments has been performed and the segments that offer the maximum opportunity for growth have been highlighted.

The study further delves into the business dynamics of major players in the industry that together form around 70% of the global IVD market. To provide a thorough understanding of the Company's business model, Company's current and historical financials have been analyzed. Also, the Company's revenue from IVD has been depicted, with a further breakup by clinical segment. The study also portrays some of the profiled Company's strengths and weaknesses that will help the reader to better position their company vis-à-vis competition.

Table of Contents

1. Analyst View

2. Research Methodology

3. In Vitro Diagnostic Market Overview

  • 3.1. Introduction
  • 3.2. What is In Vitro Diagnostics?
  • 3.3. Market Size and Growth

4. Clinical Segmentation Outlook 2018

  • 4.1. Point-of-Care Diagnostics
  • 4.2. Immunochemistry
  • 4.3. Clinical Chemistry
  • 4.4. Molecular Diagnostics
  • 4.5. Hematology
  • 4.6. Microbiology
  • 4.7. Hemostasis
  • 4.8. Immunohematology

5. Geographical Segmentation (Current & Future Scenario - 2018)

  • 5.1. America
    • 5.1.1. United States
    • 5.1.2. Canada
    • 5.1.3. Brazil
    • 5.1.4. Mexico
  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Spain
  • 5.3. Asia-Pacific
    • 5.3.1. Japan
    • 5.3.2. China
    • 5.3.3. India

6. Industry Trends

  • 6.1. Fast Emerging Niche: Devices to Capture Circulating Tumor Cells
  • 6.2. On the Horizon: Non-Invasive Genetic Tests for Cancer
  • 6.3. Non-Invasive Prenatal Diagnostics Market Witnesses Boom
  • 6.4. Companion Diagnostics Partnerships Gear Up
  • 6.5. Predictive Cancer Diagnostic Test Market Rockets Northwards
  • 6.6. POCT: Expanding Avenues into Multiple Disease Diagnosis

7. Competitive Landscape

  • 7.1. Market Share of Top Players
  • 7.2. Key Players
    • 7.2.1. Abbott Laboratories
    • 7.2.2. Alere, Inc.
    • 7.2.3. Becton Dickinson
    • 7.2.4. Bayer HealthCare
    • 7.2.5. Beckman Coulter
    • 7.2.6. Biomerieux
    • 7.2.7. Johnson and Johnson
    • 7.2.8. Life Technologies Corporation
    • 7.2.9. Medtronic, Inc.
    • 7.2.10. Qiagen NV
    • 7.2.11. Roche Holding Ltd
    • 7.2.12. Sysmex Corporation
    • 7.2.13. Siemens HealthCare
    • 7.2.14. Thermo Fisher Scientific

List of Figures:

  • Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 4-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 4-2: Global - Point-of-Care Testing Market by Region (%), 2013
  • Figure 4-3: Global - Point-of-Care Testing Market by Players (%), 2013
  • Figure 4-4: Global - Point-of-Care Testing Market (Billion US$), 2013-2018
  • Figure 4-5: Global - Immunochemistry Testing Market by Region (%), 2013
  • Figure 4-6: Global - Immunochemistry Testing Market by Players (%), 2013
  • Figure 4-7: Global - Immunochemistry Testing Market (Billion US$), 2013-2018
  • Figure 4-8: Global - Clinical Chemistry Testing Market by Region (%), 2013
  • Figure 4-9: Global - Clinical Chemistry Testing Market by Players (%), 2013
  • Figure 4-10: Global - Clinical Chemistry Testing Market (Billion US$), 2013-2018
  • Figure 4-11: Global - Molecular Diagnostics Market by Region (%), 2013
  • Figure 4-12: Global - Molecular Diagnostics Market by Players (%), 2013
  • Figure 4-13: Global - Molecular Diagnostics Market (Billion US$), 2013-2018
  • Figure 4-14: Global - Hematology Testing Market by Region (%), 2013
  • Figure 4-15: Global - Hematology Testing Market by Players (%), 2013
  • Figure 4-16: Global - Hematology Testing Market (Billion US$), 2013-2018
  • Figure 4-17: Global - Microbiology Testing Market by Region (%), 2013
  • Figure 4-18: Global - Microbiology Testing Market by Players (%), 2013
  • Figure 4-19: Global - Microbiology Testing Market (Billion US$), 2013-2018
  • Figure 4-20: Global - Hemostasis Testing Market by Region (%), 2013
  • Figure 4-21: Global - Hemostasis Testing Market by Players (%), 2013
  • Figure 4-22: Global - Hemostasis Testing Market (Billion US$), 2013-2018
  • Figure 4-23: Global - Immunohematology Testing Market by Region (%), 2013
  • Figure 4-24: Global - Immunohematology Testing Market (Billion US$), 2013-2018
  • Figure 5-1: Global - In Vitro Diagnostic Market by Region (%), 2013
  • Figure 5-2: Global - In Vitro Diagnostic Market by Region (%), 2018
  • Figure 5-3: US - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-4: US - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-5: US - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-6: Canada - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-7: Canada - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-8: Canada - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-9: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-10: Brazil - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-11: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-12: Mexico - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-13: Mexico - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-14: Mexico - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-15: Europe - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-16: Europe - In Vitro Diagnostic Market by Country (%), 2013
  • Figure 5-17: Europe - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-18: Europe - In Vitro Diagnostic Market by Country (%), 2018
  • Figure 5-19: Europe - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-20: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-21: Germany - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-22: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-23: France - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-24: France - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-25: France - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-26: Italy - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-27: Italy - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-28: Italy - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-29: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-30: UK - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-31: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-32: Spain - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-33: Spain - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-34: Spain - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-35: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-36: Japan - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-37: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-38: China - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-39: China - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-40: China - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 5-41: India - In Vitro Diagnostic Market by Clinical Segment (%), 2013
  • Figure 5-42: India - In Vitro Diagnostic Market (Billion US$), 2013-2018
  • Figure 5-43: India - In Vitro Diagnostic Market by Clinical Segment (%), 2018
  • Figure 7-1: Global - In Vitro Diagnostic Market by Players (%), 2013
  • Figure 7-2: Abbott Laboratories - Break up of Revenue by Business Segment (%), 2013
  • Figure 7-3: Abbott Laboratories - Diagnostic Division Revenue by Segment (%), 2013
  • Figure 7-4: Alere Inc. - Break up of Revenue by Business Segment (%), 2012
  • Figure 7-5: Alere Inc. - Diagnostic Division Revenue by Segment (%), 2012
  • Figure 7-6: Becton Dickinson - Break up of Revenue by Business Segment (%), 2013
  • Figure 7-7: Becton Dickinson - Diagnostic Division Revenue by Segment (%), 2013
  • Figure 7-8: Bayer HealthCare - Break up of Revenue by Business Segment (%), 2013
  • Figure 7-9: Bayer HealthCare - Consumer Health Revenue by Segment (%), 2013
  • Figure 7-10: Beckman Coulter - Break up of Revenue by Business Segment (%), 2010
  • Figure 7-11: Beckman Coulter - Diagnostic Division Revenue by Segment (%), 2010
  • Figure 7-12: Biomerieux - Break up of Revenue by Business Segment (%), 2013
  • Figure 7-13: Biomerieux - Diagnostic Division Revenue by Segment (%), 2013
  • Figure 7-14: Johnson & Johnson - Break up of Revenue by Business Segment (%), 2013
  • Figure 7-15: Life Technologies Corporation - Break up of Revenue by Business Segment (%), 2012
  • Figure 7-16: Medtronic Inc. - Break up of Revenue by Business Segment (%), 2013
  • Figure 7-17: Qiagen NV - Break up of Revenue by Business Segment (%), 2013
  • Figure 7-18: Roche Holdings Ltd - Break up of Revenue by Business Segment (%), 2013
  • Figure 7-19: Roche Holdings Ltd - Diagnostic Division Revenue by Segment (%), 2013
  • Figure 7-20: Sysmex Corp. - Break up of Revenue by Business Segment (%), 2013
  • Figure 7-21: Sysmex Corp. - Diagnostic Division Revenue by Segment (%), 2013
  • Figure 7-22: Siemens HealthCare - Diagnostic Division Revenue by Segment (%), 2013
  • Figure 7-23: Thermo Fisher Scientific - Break up of Revenue by Business Segment (%), 2012

List of Tables:

  • Table 4-1: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2013
  • Table 4-2: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2018
  • Table 5-1: Europe - Percentage of People Aged 65+ Years in Top-5 IVD Markets (2013 & 2018)
  • Table 7-1: Abbott Laboratories - Key Financials (Million US$), 2011-2013
  • Table 7-2: Abbott Laboratories - Strengths and Weaknesses
  • Table 7-3: Alere Inc. - Key Financials (Million US$), 2010-2012
  • Table 7-4: Alere Inc. - Strengths and Weaknesses
  • Table 7-5: Becton Dickinson - Key Financials (Million US$), 2011-2013
  • Table 7-6: Becton Dickinson - Strengths and Weaknesses
  • Table 7-7: Bayer HealthCare - Key Financials (Million €), 2011-2013
  • Table 7-8: Bayer HealthCare - Strengths and Weaknesses
  • Table 7-9: Beckman Coulter - Strengths and Weaknesses
  • Table 7-10: Biomerieux - Key Financials (Million €), 2011-2013
  • Table 7-11: Biomerieux - Strengths and Weaknesses
  • Table 7-12: Johnson & Johnson - Key Financials (Million US$), 2011-2013
  • Table 7-13: Johnson & Johnson - Strengths and Weaknesses
  • Table 7-14: Life Technologies Corporation - Key Financials (Million US$), 2010-2012
  • Table 7-15; Life Technologies Corporation - Strengths and Weaknesses
  • Table 7-16: Medtronic Inc. - Key Financials (Million US$), 2011-2013
  • Table 7-17; Medtronic Inc. - Strengths and Weaknesses
  • Table 7-18: Qiagen NV - Key Financials (Million US$), 2011-2013
  • Table 7-19: Qiagen NV - Strengths and Weaknesses
  • Table 7-20: Roche Holding Ltd - Key Financials (Million CHF), 2011-2013
  • Table 7-21; Roche Holding Ltd - Strengths and Weaknesses
  • Table 7-22: Sysmex Corp. - Key Financials (Million Yen), 2011-2013
  • Table 7-23: Sysmex Corp. - Strengths and Weaknesses
  • Table 7-24: Siemens AG - Key Financials (Million €), 2011-2013
  • Table 7-25: Siemens - Strength and Weaknesses
  • Table 7-26: Thermo Fisher Scientific - Key Financials (Million US$) 2010-2012
  • Table 7-27: Thermo Fisher Scientific Inc. - Strengths and Weaknesses
Back to Top